Gleolan

This newly-FDA approved, optical imaging agent turns glioma brain tumors bright pink to increase their visibility under a special blue light. Gleolan helps the surgeon more easily identify the full tumor helping ensure more complete tumor removal and a better result for the patient.

Gleolan is one of several treatment options we offer our patients. From radiation and chemotherapy, to minimally invasive surgery, to clinical trials, our neuro-oncology team has all the tools to help our patients battle complex spine and brain tumors.